GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Debt-to-Asset

Fractyl Health (Fractyl Health) Debt-to-Asset : 0.37 (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health Debt-to-Asset?

Fractyl Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $3.59 Mil. Fractyl Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $56.94 Mil. Fractyl Health's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was $163.52 Mil. Fractyl Health's debt to asset for the quarter that ended in Mar. 2024 was 0.37.


Fractyl Health Debt-to-Asset Historical Data

The historical data trend for Fractyl Health's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fractyl Health Debt-to-Asset Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
1.67 0.44 0.17 0.32 1.13

Fractyl Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.97 0.98 1.13 0.37

Competitive Comparison of Fractyl Health's Debt-to-Asset

For the Biotechnology subindustry, Fractyl Health's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fractyl Health's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Fractyl Health's Debt-to-Asset falls into.



Fractyl Health Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Fractyl Health's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Fractyl Health's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3.592 + 56.941) / 163.519
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fractyl Health  (NAS:GUTS) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Fractyl Health Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Fractyl Health's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Fractyl Health (Fractyl Health) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hartwell Avenue, Lexington, MA, USA, 02421
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.